Pediatric Multicenter Study of REPEL-CV

NCT00116233 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2005-06-28

No results posted yet for this study

Summary

This trial will study REPEL-CV for reducing post operative adhesions following cardiovascular (cv) surgery.

Conditions

  • Adhesions

Interventions

DEVICE

REPEL-CV

Sponsors & Collaborators

  • SyntheMed

    lead INDUSTRY

Principal Investigators

  • Eli Pines · SyntheMed

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00116233 on ClinicalTrials.gov